Back
Artiva Biotherapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
ARTV
Artiva Biotherapeutics, Inc.
Last Price:
$4.30
Seasonality Move:
-1.06%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ARTV is experiencing slight selling pressure.
Artiva Biotherapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.58 | Sell |
| 20-day SMA: | 3.86 | Buy |
| 50-day SMA: | 3.88 | Buy |
| 200-day SMA: | 2.95 | Buy |
| 8-day EMA: | 4.36 | Sell |
| 20-day EMA: | 4.04 | Buy |
| 50-day EMA: | 3.75 | Buy |
| 200-day EMA: | 3.73 | Buy |
Artiva Biotherapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 53.24 | Buy |
| Chaikin Money Flow: | -5282 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.03 - 4.51) | Buy |
| Bollinger Bands (100): | (2.58 - 4.14) | Buy |
Artiva Biotherapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Artiva Biotherapeutics, Inc. Stock
Is Artiva Biotherapeutics, Inc. Stock a Buy?
-
Artiva Biotherapeutics, Inc. share price is 4.30 while ARTV 8-day simple moving average is 4.58, which is a Sell signal.
-
The stock price of ARTV is 4.30 while Artiva Biotherapeutics, Inc. 20-day SMA is 3.86, which makes it a Buy.
-
Artiva Biotherapeutics, Inc. 50-day simple moving average is 3.88 while ARTV share price is 4.30, making it a Buy technically.
-
ARTV stock price is 4.30 and Artiva Biotherapeutics, Inc. 200-day simple moving average is 2.95, creating a Buy signal.
ARTV Technical Analysis vs Fundamental Analysis
Buy
69
Artiva Biotherapeutics, Inc. (ARTV)
is a Buy
Is Artiva Biotherapeutics, Inc. a Buy or a Sell?
-
Artiva Biotherapeutics, Inc. stock is rated a BuyThe current Artiva Biotherapeutics, Inc. [ARTV] share price is $4.30. The Score for ARTV is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Artiva Biotherapeutics, Inc. Stock Info
Market Cap:
104.8M
Price in USD:
4.30
Share Volume:
163.7K
Artiva Biotherapeutics, Inc. 52-Week Range
52-Week High:
11.55
52-Week Low:
1.47
Buy
69
Artiva Biotherapeutics, Inc. (ARTV)
is a Buy
Artiva Biotherapeutics, Inc. Share Price Forecast
-
What is the Artiva Biotherapeutics, Inc. stock price today?The Artiva Biotherapeutics, Inc. stock price is 4.30 USD today.
-
Will ARTV stock go up or go down?Artiva Biotherapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Artiva Biotherapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Artiva Biotherapeutics, Inc. is not overvalued.
Is Artiva Biotherapeutics, Inc. Stock a Buy?
-
Artiva Biotherapeutics, Inc. share price is 4.30 while ARTV 8-day exponential moving average is 4.36, which is a Sell signal.
-
The stock price of ARTV is 4.30 while Artiva Biotherapeutics, Inc. 20-day EMA is 4.04, which makes it a Buy.
-
Artiva Biotherapeutics, Inc. 50-day exponential moving average is 3.75 while ARTV share price is 4.30, making it a Buy technically.
-
ARTV stock price is 4.30 and Artiva Biotherapeutics, Inc. 200-day simple moving average is 3.73, creating a Buy signal.
Fundamental Analysis of Artiva Biotherapeutics, Inc.
Is Artiva Biotherapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.99 per share, and an increase next year of $0.52 per share.
Technical Analysis of Artiva Biotherapeutics, Inc.
Should I short Artiva Biotherapeutics, Inc. stock?
-
ARTV Moving Average Covergence Divergence (MACD) indicator is 0.27, suggesting Artiva Biotherapeutics, Inc. is a Buy
-
Artiva Biotherapeutics, Inc. Relative Strength Index (RSI) is 53.24, which suggest Artiva Biotherapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Artiva Biotherapeutics, Inc. is (3.03 - 4.51), which suggest Artiva Biotherapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Artiva Biotherapeutics, Inc. is (2.58 - 4.14), which suggest Artiva Biotherapeutics, Inc. is a Buy
* Artiva Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.